to IP with antibody to EBNA1 or control IgG, and then assayed by Western blot with antibody to Survivin or EBNA1, as indicated. The data is a biological replicate of that shown in Figure 8D , except that input levels of EBNA1 are not adjusted relative the input levels for Survivin (5% input for all samples). www.impactjournals.com/oncotarget Figure 8H were quantified by PhosphorImager for biological replicates harvested at 4 days or 7 days post-transduction with lentivirus shCtrl or shSurvivin in either MUTU I (top) or RAJI (lower) cells.
